Your browser doesn't support javascript.
loading
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention.
Cavallari, Larisa H; Limdi, Nita A; Beitelshees, Amber L; Lee, James C; Duarte, Julio D; Franchi, Francesco; Tuteja, Sony; Giri, Jay; Empey, Philip E; Kreutz, Rolf P; Skaar, Todd C; Allen, John M; Coons, James C; Gong, Yan; McDonough, Caitrin W; Stevenson, James M; Thomas, Cameron D; Johnson, Julie A; Stouffer, George A; Angiolillo, Dominick J; Lee, Craig R.
Affiliation
  • Cavallari LH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Limdi NA; Department of Neurology, Program for Translational Pharmacogenomics and Hugh Kaul Personalized Medicine Institute, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Beitelshees AL; Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Lee JC; Department of Pharmacy Practice, University of Illinois Chicago, Chicago, Illinois, USA.
  • Duarte JD; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Franchi F; University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.
  • Tuteja S; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Giri J; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Empey PE; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
  • Kreutz RP; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Skaar TC; Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Allen JM; Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Orlando, Florida, USA.
  • Coons JC; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
  • Gong Y; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • McDonough CW; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Stevenson JM; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
  • Thomas CD; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Johnson JA; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Stouffer GA; Division of Cardiology and McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Angiolillo DJ; University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA.
  • Lee CR; Division of Cardiology and McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina, USA.
Clin Pharmacol Ther ; 113(3): 615-623, 2023 03.
Article in En | MEDLINE | ID: mdl-36306392

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Percutaneous Coronary Intervention Type of study: Prognostic_studies Aspects: Equity_inequality Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Percutaneous Coronary Intervention Type of study: Prognostic_studies Aspects: Equity_inequality Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos